First Light Asset Management as of Sept. 30, 2016
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 68 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| NeoGenomics (NEO) | 7.2 | $17M | 2.0M | 8.22 | |
| AtriCure (ATRC) | 6.3 | $15M | 930k | 15.82 | |
| Akorn | 6.2 | $14M | 526k | 27.26 | |
| Oxford Immunotec Global | 3.9 | $9.1M | 724k | 12.56 | |
| Entellus Medical Cm | 3.7 | $8.7M | 391k | 22.18 | |
| LHC | 3.5 | $8.2M | 223k | 36.88 | |
| HealthStream (HSTM) | 3.5 | $8.1M | 292k | 27.60 | |
| Harvard Bioscience (HBIO) | 3.3 | $7.7M | 2.8M | 2.72 | |
| Teligent | 3.3 | $7.6M | 996k | 7.60 | |
| Array BioPharma | 2.9 | $6.7M | 986k | 6.75 | |
| NxStage Medical | 2.7 | $6.3M | 250k | 24.99 | |
| BioScrip | 2.6 | $6.1M | 2.1M | 2.89 | |
| Orthofix International Nv Com Stk | 2.5 | $5.9M | 137k | 42.77 | |
| Amedisys (AMED) | 2.3 | $5.3M | 113k | 47.44 | |
| Enzo Biochem (ENZB) | 2.3 | $5.3M | 1.0M | 5.09 | |
| K2m Group Holdings | 2.1 | $4.9M | 275k | 17.78 | |
| Spectranetics Corporation | 2.1 | $4.9M | 194k | 25.09 | |
| Medicines Company | 2.0 | $4.8M | 126k | 37.74 | |
| Cynapsus Therapeutics | 2.0 | $4.8M | 118k | 40.23 | |
| Bluebird Bio | 2.0 | $4.6M | 68k | 67.78 | |
| Model N (MODN) | 1.9 | $4.4M | 395k | 11.11 | |
| Aratana Therapeutics | 1.9 | $4.4M | 468k | 9.36 | |
| Veracyte (VCYT) | 1.9 | $4.4M | 574k | 7.61 | |
| Sage Therapeutics (SAGE) | 1.9 | $4.3M | 94k | 46.05 | |
| Ligand Pharmaceuticals In (LGND) | 1.8 | $4.2M | 41k | 102.07 | |
| Shire | 1.6 | $3.8M | 20k | 193.85 | |
| LeMaitre Vascular (LMAT) | 1.6 | $3.6M | 183k | 19.84 | |
| Endologix | 1.4 | $3.3M | 257k | 12.80 | |
| Physicians Realty Trust | 1.4 | $3.3M | 152k | 21.54 | |
| Immunomedics | 1.4 | $3.2M | 993k | 3.25 | |
| Streamline Health Solutions | 1.4 | $3.2M | 1.8M | 1.84 | |
| Cepheid | 1.4 | $3.2M | 61k | 52.69 | |
| BioMarin Pharmaceutical (BMRN) | 1.3 | $3.0M | 32k | 92.50 | |
| Alkermes (ALKS) | 1.2 | $2.9M | 61k | 47.03 | |
| Bio-techne Corporation (TECH) | 1.1 | $2.6M | 24k | 109.49 | |
| Tearlab Corp | 1.0 | $2.3M | 3.6M | 0.65 | |
| Nanostring Technologies (NSTGQ) | 1.0 | $2.3M | 116k | 19.98 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.9 | $2.0M | 23k | 87.22 | |
| RTI Biologics | 0.8 | $1.9M | 599k | 3.13 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $1.9M | 51k | 36.65 | |
| Quidel Corporation | 0.8 | $1.8M | 82k | 22.09 | |
| Biotelemetry | 0.8 | $1.8M | 95k | 18.57 | |
| Becton, Dickinson and (BDX) | 0.3 | $610k | 3.4k | 179.68 | |
| Chembio Diagnostics | 0.2 | $577k | 78k | 7.40 | |
| SPDR S&P Biotech (XBI) | 0.2 | $503k | 7.6k | 66.27 | |
| Novartis (NVS) | 0.2 | $479k | 6.1k | 78.91 | |
| Avinger | 0.2 | $461k | 97k | 4.77 | |
| Allergan | 0.2 | $469k | 2.0k | 230.47 | |
| Steris | 0.2 | $463k | 6.3k | 73.14 | |
| Johnson & Johnson (JNJ) | 0.2 | $451k | 3.8k | 118.06 | |
| Eli Lilly & Co. (LLY) | 0.2 | $441k | 5.5k | 80.25 | |
| Bristol Myers Squibb (BMY) | 0.2 | $447k | 8.3k | 53.92 | |
| Celgene Corporation | 0.2 | $447k | 4.3k | 104.44 | |
| United Therapeutics Corporation (UTHR) | 0.2 | $451k | 3.8k | 118.06 | |
| Merck & Co (MRK) | 0.2 | $413k | 6.6k | 62.48 | |
| Amgen (AMGN) | 0.2 | $389k | 2.3k | 166.95 | |
| AstraZeneca (AZN) | 0.2 | $373k | 11k | 32.83 | |
| Mylan Nv | 0.2 | $373k | 9.8k | 38.16 | |
| Pfizer (PFE) | 0.1 | $356k | 11k | 33.84 | |
| Aetna | 0.1 | $301k | 2.6k | 115.59 | |
| Humana (HUM) | 0.1 | $313k | 1.8k | 177.04 | |
| St. Jude Medical | 0.1 | $312k | 3.9k | 79.77 | |
| Bio-Rad Laboratories (BIO) | 0.1 | $274k | 1.7k | 163.58 | |
| Agile Therapeutics | 0.1 | $261k | 37k | 6.97 | |
| Anthem (ELV) | 0.1 | $257k | 2.0k | 125.55 | |
| Agilent Technologies Inc C ommon (A) | 0.1 | $241k | 5.1k | 47.07 | |
| Sanofi-Aventis SA (SNY) | 0.1 | $217k | 5.7k | 38.20 | |
| IRIDEX Corporation (IRIX) | 0.1 | $149k | 10k | 14.45 |